Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 25;10(11):2296.
doi: 10.3390/jcm10112296.

Optical Coherence Tomography Angiography Metrics Monitor Severity Progression of Diabetic Retinopathy-3-Year Longitudinal Study

Affiliations

Optical Coherence Tomography Angiography Metrics Monitor Severity Progression of Diabetic Retinopathy-3-Year Longitudinal Study

Inês P Marques et al. J Clin Med. .

Abstract

To examine retinal vessel closure metrics and neurodegenerative changes occurring in the initial stages of nonproliferative diabetic retinopathy (NPDR) and severity progression in a three-year period. Methods: Three-year prospective longitudinal observational cohort of individuals with type 2 diabetes (T2D), one eye per person, using spectral domain-optical coherence tomography (SD-OCT) and OCT-Angiography (OCTA). Eyes were examined four times with one-year intervals. OCTA vessel density maps of the retina were used to quantify vessel closure. Thickness of the ganglion cell + inner plexiform layer (GCL + IPL) was examined to identify retinal neurodegenerative changes. Diabetic retinopathy ETDRS classification was performed using the seven-field ETDRS protocol. Results: A total of 78 eyes/patients, aged 52 to 80 years, with T2D and ETDRS grades from 10 to 47 were followed for 3 years with annual examinations. A progressive increase in retinal vessel closure was observed. Vessel density (VD) showed higher decreases with retinopathy worsening demonstrated by step-changes in ETDRS severity scale (p < 0.001). No clear correlation was observed between neurodegenerative changes and retinopathy progression. Conclusions: Retinal vessel closure in NPDR correlates with DR severity progression. Our findings provide supporting evidence that OCTA metrics of vessel closure may be used as a surrogate for DR severity progression.

Keywords: OCTA; diabetes; ischemia; retinopathy; severity.

PubMed Disclaimer

Conflict of interest statement

I.P.M., T.S., L.M., M.H.M., D.T., A.R.S. and C.L. declare no conflict of interests. Disclosures: S.K., L.d.S., W.L. and M.K.D. are employees of Carl Zeiss Meditec; J.C.-V. reports grants from Carl Zeiss Meditec and is a consultant for Alimera Sciences, Allergan, Bayer, Gene Signal, Novartis, Pfizer, Precision Ocular Ltd., Roche, Sanofi-Aventis, Vifor Pharma, and Carl Zeiss Meditec.

Figures

Figure 1
Figure 1
Schematic representation of individual vessel density values in the SCP inner ring and thinning of GCL + IPL and its progression over the four visits, presented according to differences and variation in VD across ETDRS groups. The values are given in relation to the control group: Values within a normal range are depicted in green; 2 SD decrease is depicted in red; 1 SD decrease is depicted in yellow; and 2 SD increase are shown in blue. Circles without color indicate that reliable measurements could not be obtained in that specific visit due to insufficient image quality. Arrows indicate ETDRS step progression: one or two increase (↑), maintenance (-) or decrease (↓). VD: Vessel density; GCL: Ganglion cell layer and Inner plexiform layers. V1: Baseline visit; V2: 1 year visit; V3: 2-year visit; V4: Last visit (3 years).

References

    1. Bourne R.R.A., Stevens G.A., White R.A., Smith J.L., Flaxman S.R., Price H., Jonas J.B., Keeffe J., Leasher J., Naidoo K., et al. Causes of vision loss worldwide, 1990–2010: A systematic analysis. Lancet Glob. Health. 2013;1:e339–e349. doi: 10.1016/S2214-109X(13)70113-X. - DOI - PubMed
    1. Marques I.P., Alves D., Santos T., Mendes L., Santos A.R., Lobo C., Durbin M., Cunha-Vaz J. Multimodal Imaging of the Initial Stages of Diabetic Retinopathy: Different Disease Pathways in Different Patients. Diabetes. 2019;68:648–653. doi: 10.2337/db18-1077. - DOI - PubMed
    1. Nunes S., Ribeiro L., Lobo C., Cunhavaz J.G. Three Different Phenotypes of Mild Nonproliferative Diabetic Retinopathy With Different Risks for Development of Clinically Significant Macular Edema. Investig. Opthalmology Vis. Sci. 2013;54:4595–4604. doi: 10.1167/iovs.13-11895. - DOI - PubMed
    1. Cunhavaz J.G., Bernardes R., Santos T., Oliveira C., Lobo C., Pires I., Ribeiro L. Computer-Aided Detection of Diabetic Retinopathy Progression. Digit. Teleretinal Screen. 2012;226:59–66. doi: 10.1007/978-3-642-25810-7_6. - DOI
    1. Marques I.P., Madeira M.H., Messias A.L., Santos T., Martinho A.C.-V., Figueira J., Cunha-Vaz J. Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy. J. Clin. Med. 2020;9:1433. doi: 10.3390/jcm9051433. - DOI - PMC - PubMed

LinkOut - more resources